Samsung Ventures has exited medical software developer CareInSync after Hearst followed up an equity investment by acquiring the company.

The biotechnology company has closed the funding round it started in December 2013.

California-based Synack has raised series A capital from Google Ventures and aims to deliver an advanced new model for vulnerability and security testing of enterprise software.

Bangalore-based SeQuent Scientific has acquired a stake worth almost 16% in pharmaceutical ingredient developer Shasun Pharmaceuticals.

Sotera Wireless, a portfolio company of Intel Capital and Qualcomm Ventures, has secured $20m in a round that has taken its overall funding to $78m.

The spin-out from Queen's University Belfast secured the cash injection from NetScientific and Qubis.

Aerpio Therapeutics, a developer of drugs to combat vascular diseases, has raised $22m in a round featuring pharmaceutical company Novartis.

The new start-up will focus on creating technology-based solutions for people with motor limitations.

A spin-out from the National University of Ireland, Galway (NUIG), Orbsen Therapeutics will partner with Birmingham University.